.
Feedback

Mothers with Infants Invited to Participate in Two Autism Studies

Title: Mothers with Infants Invited to Participate in Two Autism Studies

Description

Researchers at the University of Connecticut are looking for pregnant mothers and mothers with infants to participate in two research initiatives that will follow the development of infant siblings of children with autism over the first two years of life.

These studies are being conducted by Deborah Fein, a UConn Board of Trustees distinguished professor of psychology and nationally-recognized leader in autism research, and Anjana Bhat, an assistant professor in UConn's Neag School of Education who studies developmental disorders in infants and children.

The UConn IRB has approved these studies, Protocol #'s: H08-234 and H08-111.

 

Who Can Participate

  • Younger siblings of children with autism between 16 and 30 months of age may be eligible to participate in the Early Detection Sibling Study.
  • Infant siblings of children with autism between 3 and 12 months of age may be eligible to participate in the Infant Learning Study and may continue to participate in the Early Detection Sibling Study after 16 months of age.

 

 What the Early Detection Sibling Study Involves

  • Professor Fein and her research team are studying the use of a developmental screener to see how well it works with younger siblings of children with an autism spectrum disorder.
  • Parents of eligible younger siblings will complete developmental questionnaires for their younger child when he/she is aged 18 months and 24 months.  Parents will also be asked to complete a behavioral questionnaire for their older child.
  • Some families will be given a follow-up phone interview and asked to come to the University of Connecticut-Storrs to receive a free developmental and diagnostic evaluation.

 

 What the Infant Learning Study Involves

  • You and your infant will visit Assistant Professor Bhat's lab twice or someone from the lab will visit your home twice when your infant in 3, 6, 9, 12, and 15 months for a total of 10 visits.  Each visit lasts 1-1.5 hours.
  • You and your infant will participate in a number of play-oriented, structured activities.
  • You will receive a few questionnaires to follow-up on your child's development when your child is 18 and 24 months.  A researcher may also conduct a phone interview to confirm your responses.
  • If you live far away and we cannot drive to you, you can still participate in our research study via skype videochat sessions and by filling out parent questionnaires.  We will provide you a testing kit to accomplish the web-based assessments at each age.

 

How You Can Help

You can help by volunteering for the studies.  If you have questions on the Early Detection Sibling Study, please call the study office at (860) 486-5767.

If you have questions on the Infant Learning Study, please call the Infant Development Lab at (860) 486-0019 or email to anjana.bhat@uconn.edu

Newsletter & Alerts

Get the best stories each day and important breaking news

Subscribe

Not from Pacifica Patch? Find your Local Patch »

Loading comments ...
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors. Write a new post... What's up? Make an announcement, speak your mind, or sell something
Hnin May 24, 2013 at 06:31 pm
Please help share it on your facebook as well. Anything to find our cat.Read More http://sfbay.craigslist.org/pen/laf/3825190526.html
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section youRead More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety inRead More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available. There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing. I note that none of the companies mentioned here, nor the FDA, has provided input to this article. The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people. The science is just plain flawed.
Pacificat April 12, 2013 at 12:49 pm
Please tell us in what ways it is ill-informed
Anon. April 11, 2013 at 08:22 pm
Ill-informed, sensationalist rubbish.
Deb Wong March 26, 2013 at 06:09 pm
Thanks, Stacie!
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusingRead More your photo gallery.